These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 17428619)
1. Huntington's disease and HDACi: would sulpiride and valproate be of therapeutic value? Tremolizzo L; Rodriguez-Menendez V; DiFrancesco JC; Sala G; Galbussera A; Appollonio I; Ferrarese C Med Hypotheses; 2007; 69(4):964-5. PubMed ID: 17428619 [No Abstract] [Full Text] [Related]
2. Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington's disease. Zádori D; Geisz A; Vámos E; Vécsei L; Klivényi P Pharmacol Biochem Behav; 2009 Nov; 94(1):148-53. PubMed ID: 19698736 [TBL] [Abstract][Full Text] [Related]
3. Improvement of Huntington's disease with olanzapine and valproate. Grove VE; Quintanilla J; DeVaney GT N Engl J Med; 2000 Sep; 343(13):973-4. PubMed ID: 11012330 [No Abstract] [Full Text] [Related]
4. [Good effect of valproate against aggression in Huntington disease. Only two cases reported earlier]. Rask G; Andersson C Lakartidningen; 2010 Dec 1-7; 107(48):3060-1. PubMed ID: 21287753 [No Abstract] [Full Text] [Related]
5. Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series. Saft C; Lauter T; Kraus PH; Przuntek H; Andrich JE BMC Neurol; 2006 Feb; 6():11. PubMed ID: 16507108 [TBL] [Abstract][Full Text] [Related]
6. Hypokinesia in Huntington's disease. van Vugt JP; van Hilten BJ; Roos RA Mov Disord; 1996 Jul; 11(4):384-8. PubMed ID: 8813217 [TBL] [Abstract][Full Text] [Related]
8. Treatment of Huntington's chorea with sulpiride. Knowling MR; Wrench W S Afr Med J; 1991 Feb; 79(3):169. PubMed ID: 1825239 [No Abstract] [Full Text] [Related]
9. Pisa syndrome and parkinsonism secondary to valproic acid in Huntington's disease. Salazar Z; Tschopp L; Calandra C; Micheli F Mov Disord; 2008 Dec; 23(16):2430-1. PubMed ID: 18823027 [No Abstract] [Full Text] [Related]
10. Drug holiday in Huntington's disease. Schmidt EZ; Hofmann P; Kapfhammer HP; Bonelli RM Ann Pharmacother; 2005 Apr; 39(4):773. PubMed ID: 15741414 [No Abstract] [Full Text] [Related]
11. [The Cools and van Rossum theory and the pharmacology of Huntington's chorea]. Donatelli L Clin Ter; 1977 Jun; 81(5):395-416. PubMed ID: 18317 [No Abstract] [Full Text] [Related]
16. A Europe-wide assessment of current medication choices in Huntington's disease. Priller J; Ecker D; Landwehrmeyer B; Craufurd D Mov Disord; 2008 Sep; 23(12):1788. PubMed ID: 18649399 [No Abstract] [Full Text] [Related]
17. Emerging drug therapies in Huntington's disease. Mason SL; Barker RA Expert Opin Emerg Drugs; 2009 Jun; 14(2):273-97. PubMed ID: 19453283 [TBL] [Abstract][Full Text] [Related]
18. [Recent neurobiological and related pharmaco-therapeutic acquisitions in Huntington's chorea]. Carolei A; Del Castillo G Clin Ter; 1979 Sep; 90(6):591-621. PubMed ID: 43793 [No Abstract] [Full Text] [Related]
19. Sodium valproate in chorea. Br Med J; 1976 Dec; 2(6051):1562. PubMed ID: 137765 [No Abstract] [Full Text] [Related]
20. Increase in antiepileptic efficacy during prolonged treatment with valproic acid: role of inhibition of histone deacetylases? Hoffmann K; Czapp M; Löscher W Epilepsy Res; 2008 Oct; 81(2-3):107-13. PubMed ID: 18538545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]